98110: A Randomized Phase II Dose Finding Study of ArginMax with or without Phosphodiesterase-5 Inhibitors for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated with Radiotherapy (1 credit)

This study is closed to accrual.  The accrual goal was reached on 11/13/2013. 

Most Recent Protocol Documents (3)

Protocol  •  Site Consent  •  WFU Consent*  •  Changes  •  Approval Letter

*The most recent WFU consent is from the 2013 Continuing Review.

 
  Appendices  •  Archived Amendments  •  Adverse Events   

Quick Reference

Research Base

Fax 336-716-6275
Phone 336-716-0891

2000 West First Street
Protocol Information Office
Suite 101
Winston-Salem, NC 27104
Find A Doctor Ways to Give
Last Updated: 02-11-2014
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.